Thursday, Oct 22, 2026
Focus on the big picture

Biogen shares soar on landmark Alzheimer's data

Reuters, 29 Sep 2022
Shares of Biogen soared more than 40% after a surprise successful trial of its experimental Alzheimer's drug.

#Biogen #Alzheimer #Pharma #News #Reuters #newsfeed

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Related Articles